For buyers
Cannabis due diligence overview
Federal and state law current as of September 2026 — verify with counsel.
Key takeaways
- People, premises, product, tax.
- Track-and-trace beats a vanity P&L.
- Local authorization is a file.
- No control before approval.
- SBA will not save a thin buyer.
Cannabis due diligence overview is a verification order: people, premises, product movement, and tax. This page is written for buyers and for more than one license class. It is not legal or tax advice. Federal and state law current as of September 2026 — verify with counsel.
Treat Cannabis due diligence overview as a state-license file with a federal tax and banking overlay. Schedule III medical relief is real for qualifying activity and irrelevant to an adult-use-only book. Hemp SKUs face CRS IN12620 on the 2026 hemp definition on 12 November 2026. Do not import a 2021 multiple onto that fact pattern.
| Topic | Working rule (verify, September 2026) |
|---|---|
| Audience | buyers |
| License lens | more than one license class |
| Contrast markets | Colorado / Connecticut / New Jersey |
| SBA | Unavailable for plant-touching (SOP 50 10 8) |
| Hemp clock | P.L. 119-37 redefinition 12 November 2026 |
| Commentary multiple (not an appraisal) | 5x–53x normalized earnings |
Colorado habits that fail on Cannabis due diligence overview — what belongs on Cannabis due diligence overview?
Copying a Colorado habit into Connecticut is how Cannabis due diligence overview dies in review. New Jersey is the third check. Published locks (Maryland converted control through 1 July 2028; New Jersey majority changes; California non-assignment) only apply if the premises sit there.
Cash after tax on Cannabis due diligence overview — what belongs on Cannabis due diligence overview?
Illustrative only: $302,000 of pre-280E earnings can shrink hard on an adult-use book. Medical Schedule III relief after 28 April 2026 is a slice, not a slogan. Dual shops apportion. IRC §280E is the citation.
Capital that will not appear on Cannabis due diligence overview — how should you read this on Cannabis due diligence overview?
SBA SOP 50 10 8 still bars plant-touching 7(a) and 504. SAFE Banking Act of 2026, S.4942 is not a close condition. Cannabis due diligence overview is funded with seller paper, private credit, cash, or a sale-leaseback — or it is not funded.
Local authorization inside Cannabis due diligence overview — what belongs on Cannabis due diligence overview?
A state yes with a city no is a failed Cannabis due diligence overview. Opt-out, buffers, and CUPs are the site. Read local control before anyone argues price.
People the agency will map on Cannabis due diligence overview — how should you read this on Cannabis due diligence overview?
True parties of interest include more than the 51% owner. Silent lenders and handshake managers show up on Cannabis due diligence overview whether the CIM mentions them or not.
Confidentiality rules for Cannabis due diligence overview — why does this change Cannabis due diligence overview?
Cannabis due diligence overview is not a Facebook post. Use a blind teaser and an NDA. Employees and landlords in Colorado find out on a planned day.
Holdbacks that belong on Cannabis due diligence overview — why does this change Cannabis due diligence overview?
Tax, inventory, and compliance residuals sit in escrow or a holdback. Cannabis due diligence overview that closes “clean” with open city tax is a gift to the buyer’s counsel.
What a commentary multiple is not on Cannabis due diligence overview — why does this change Cannabis due diligence overview?
Trade notes still cite about 3x–33x normalized earnings for a clean single store. Public MSO chatter near 4.16x EV/EBITDA for 2025 is not a value for Cannabis due diligence overview.
Hemp overlay if Cannabis due diligence overview touches SKUs — how should you read this on Cannabis due diligence overview?
P.L. 119-37 and CRS IN12620 on the 2026 hemp definition reset the definition on 12 November 2026. If Cannabis due diligence overview includes delta-8 or other intoxicating hemp, underwrite the post-rule catalog.
MSA risk around Cannabis due diligence overview — how should you read this on Cannabis due diligence overview?
A management agreement that moves control before approval is a license event. Cannabis due diligence overview does not get a clever close by calling the buyer a consultant.
Diligence order for Cannabis due diligence overview — what belongs on Cannabis due diligence overview?
Eligibility, then local host status, then track-and-trace, then tax, then lease. The checklist stays in the working set.
Documents that actually move Cannabis due diligence overview — why does this change Cannabis due diligence overview?
License, local authorization, lease consent, tax clearance, 3 months of seed-to-sale exports, violation history, and the ownership chart. Missing one of those is not a formatting issue.
Who should not attempt Cannabis due diligence overview — what should you verify for Cannabis due diligence overview?
A buyer who cannot pass background or residency. An owner inside a holding period. A non-citizen who has not spoken to immigration counsel. USCIS still treats marijuana conduct as a controlled-substance issue.
How HedgeStone treats Cannabis due diligence overview — why does this change Cannabis due diligence overview?
Jason Taken will say if Cannabis due diligence overview is transferable before anyone writes a CIM. He is a business broker, not an attorney and not a licensed operator. No invented listings, no invented MSO names.
Cited sources that govern Cannabis due diligence overview: FinCEN FIN-2014-G001 remains the SAR frame banks actually use. SBA SOP 50 10 8 keeps plant-touching targets out of 7(a) and 504, including medical. SAFE Banking Act of 2026, S.4942 and H.R.9471 were introduced in 2026 and are not law. Hemp SKUs must be read against CRS IN12620 on the 2026 hemp definition and CRS IF13136; the redefinition date is 12 November 2026.
What to bring to the intro call — how should you read this on Cannabis due diligence overview?
Book twenty minutes with Jason Taken at HedgeStone Business Advisors. For Cannabis due diligence overview, bring the license class, the state, the local authorization status, and whether a buyer or target is already in the room. There is no form on this site and no invented listing book. He is a business broker, not an attorney and not a licensed cannabis operator.
Related pages for Cannabis due diligence overview — how should you read this on Cannabis due diligence overview?
Read track-and-trace next if that file is open on Cannabis due diligence overview. seller audit is the companion page when Cannabis due diligence overview needs that angle. Keep 280E in the working set for Cannabis due diligence overview. Read diligence overview next if that file is open on Cannabis due diligence overview. checklist is the companion page when Cannabis due diligence overview needs that angle. Keep red flags in the working set for Cannabis due diligence overview.
Summary on Cannabis due diligence overview — what breaks Cannabis due diligence overview?
Cannabis due diligence overview turns on approval, after-tax cash, and the license class. Federal law current as of September 2026 is a schedule split, not a green light. Verify every rate, cap, and clock with counsel.
Which public sources belong on this file?
Cite FDA cannabis / CBD page, IRS marijuana industry page, eCFR CSA schedules, USDA hemp production. A forum post is not a substitute.
How should you underwrite Cannabis due diligence overview?
Cannabis due diligence overview has to hold back as a license-and-tax file. In New York, scarcity can dominate. In Virginia, paper value can be near zero. Cited sources that govern Cannabis due diligence overview: Federal Register 2026-08176 is the April 2026 medical / FDA-approved marijuana Schedule III order. IRC §280E still disallows ordinary deductions on Schedule I trafficking, which is why adult-use books stay in 280E. FinCEN FIN-2014-G001 remains the SAR frame banks actually use. SBA SOP 50 10 8 keeps plant-touching targets out of 7(a) and 504, including medical.
| Check | New York | Virginia |
|---|---|---|
| Transfer / host | Verify agency | Verify city |
| Tax / 280E mix | Medical slice | Adult-use slice |
What does a 280E-literate CPA ask?
Cannabis due diligence overview has to document as a license-and-tax file. In Florida, scarcity can dominate. In Oklahoma, paper value can be near zero. Cited sources that govern Cannabis due diligence overview: Hemp SKUs must be read against CRS IN12620 on the 2026 hemp definition and CRS IF13136; the redefinition date is 12 November 2026. Federal Register 2026-08176 is the April 2026 medical / FDA-approved marijuana Schedule III order. IRC §280E still disallows ordinary deductions on Schedule I trafficking, which is why adult-use books stay in 280E. FinCEN FIN-2014-G001 remains the SAR frame banks actually use.
| Check | Florida | Oklahoma |
|---|---|---|
| Transfer / host | Verify agency | Verify city |
| Tax / 280E mix | Medical slice | Adult-use slice |
How should approval be sequenced?
Cannabis due diligence overview has to age as a license-and-tax file. In California, scarcity can dominate. In Pennsylvania, paper value can be near zero. Cited sources that govern Cannabis due diligence overview: FinCEN FIN-2014-G001 remains the SAR frame banks actually use. SBA SOP 50 10 8 keeps plant-touching targets out of 7(a) and 504, including medical. SAFE Banking Act of 2026, S.4942 and H.R.9471 were introduced in 2026 and are not law. Hemp SKUs must be read against CRS IN12620 on the 2026 hemp definition and CRS IF13136; the redefinition date is 12 November 2026.
| Check | California | Pennsylvania |
|---|---|---|
| Transfer / host | Verify agency | Verify city |
| Tax / 280E mix | Medical slice | Adult-use slice |
Where does the file break in Illinois versus Minnesota?
Cannabis due diligence overview has to disclose as a license-and-tax file. In Illinois, scarcity can dominate. In Minnesota, paper value can be near zero. Cited sources that govern Cannabis due diligence overview: IRC §280E still disallows ordinary deductions on Schedule I trafficking, which is why adult-use books stay in 280E. FinCEN FIN-2014-G001 remains the SAR frame banks actually use. SBA SOP 50 10 8 keeps plant-touching targets out of 7(a) and 504, including medical. SAFE Banking Act of 2026, S.4942 and H.R.9471 were introduced in 2026 and are not law.
| Check | Illinois | Minnesota |
|---|---|---|
| Transfer / host | Verify agency | Verify city |
| Tax / 280E mix | Medical slice | Adult-use slice |
Frequently asked questions
Will SBA finance a plant-touching purchase?
No. [SBA SOP 50 10 8](https://www.sba.gov/document/sop-50-10-lender-development-company-loan-programs) treats plant-touching marijuana businesses as ineligible for 7(a) and 504, including medical. cannabis due diligence needs another stack.
What does HedgeStone actually do here?
Eligibility pre-screen, confidential match, METRC-aware pricing, and an approval-contingent process. Not a guaranteed price or a guaranteed yes. That is the job on cannabis due diligence.
Is this legal or tax advice?
No. Educational only. Use cannabis-specialized counsel and a 280E-literate CPA. Jason Taken is a business broker, not an attorney and not a licensed operator.
Which records actually prove the story?
Track-and-trace, tax filings, the lease cannabis-use clause, and a cap table that matches the application. A vanity P&L is a brochure when you are underwriting cannabis due diligence.
Who should not attempt this?
A buyer who cannot pass background or residency. An owner inside a holding period. A non-citizen who has not spoken to immigration counsel. Stop before marketing cannabis due diligence.
How does local authorization change the deal?
A state yes with a city no is a failed file. Opt-out, buffers, and CUPs are the site. Read local control before anyone argues price on cannabis due diligence.
Sources
- SBA SOP 50 10 8 (effective 1 June 2025) — marijuana ineligibility — https://www.sba.gov/document/sop-50-10-lender-development-company-loan-programs
- Congress.gov S.4942 — SAFE Banking Act of 2026 (introduced, not enacted) — https://www.congress.gov/bill/119th-congress/senate-bill/4942
- Congress.gov H.R.9471 — companion SAFE Banking bill — https://www.congress.gov/bill/119th-congress/house-bill/9471
- CRS IF13136 / IN12620 — hemp definition change effective 12 November 2026 (P.L. 119-37) — https://www.congress.gov/crs-product/IN12620
- IRC §280E — https://www.law.cornell.edu/uscode/text/26/280E
- FDA cannabis and CBD page — https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd
- IRS marijuana industry — https://www.irs.gov/businesses/small-businesses-self-employed/marijuana-industry
- eCFR 21 CFR chapter II — https://www.ecfr.gov/current/title-21/chapter-II
- Federal Register 2026-08176 (28 April 2026) — medical / FDA-approved marijuana to Schedule III — https://www.federalregister.gov/d/2026-08176
- FinCEN FIN-2014-G001 — BSA expectations for marijuana-related businesses — https://www.fincen.gov/resources/statutes-regulations/guidance/bsa-expectations-regarding-marijuana-related-businesses
- Viridian Capital public commentary — Tier 1 U.S. MSO EV/EBITDA ~4.16x (2025 consensus)